CAPOBIANCO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 582
EU - Europa 171
AS - Asia 82
AF - Africa 4
OC - Oceania 1
SA - Sud America 1
Totale 841
Nazione #
US - Stati Uniti d'America 577
IT - Italia 74
SE - Svezia 50
CN - Cina 31
IN - India 27
SG - Singapore 18
FI - Finlandia 15
GB - Regno Unito 7
DE - Germania 5
FR - Francia 5
CA - Canada 4
RO - Romania 4
TG - Togo 3
UA - Ucraina 3
BG - Bulgaria 2
IE - Irlanda 2
IL - Israele 2
NL - Olanda 2
TH - Thailandia 2
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
PL - Polonia 1
Totale 841
Città #
Fairfield 92
Ashburn 60
Seattle 50
Woodbridge 46
Rome 36
Cambridge 32
Chandler 30
Ann Arbor 27
Houston 27
Beijing 26
Wilmington 25
Princeton 16
Dearborn 15
Plano 13
San Paolo di Civitate 12
San Mateo 11
Singapore 9
Boston 8
Lawrence 8
Millbury 6
Fremont 5
Milan 5
Norwalk 5
Helsinki 4
Toronto 4
Lomé 3
New York 3
Paris 3
Phoenix 3
Andover 2
Bangkok 2
Capannori 2
Dublin 2
Genova 2
Halle 2
Naples 2
San Diego 2
Sofia 2
Walthamstow 2
Abidjan 1
Amsterdam 1
Büdelsdorf 1
Camerino 1
Changchun 1
Chongqing 1
Coominya 1
Des Moines 1
Federal 1
Grafing 1
Haifa 1
Hangzhou 1
Horia 1
Jacksonville 1
Jaworzno 1
Los Angeles 1
Mexico City 1
Nanjing 1
Pune 1
Segrate 1
Serrata 1
Stockholm 1
Taiyuan 1
Tel Aviv 1
Terni 1
Todi 1
Tokyo 1
Washington 1
Zurich 1
Totale 633
Nome #
Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficialmicrobiota in relation to mode of delivery 120
A prophylactic multi-strain probiotic treatment to reduce the absorption of toxic elements. In-vitro study and biomonitoring of breast milk and infant stools 115
Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia 80
Role of lactobacilli and lactoferrin in the mucosal cervicovaginal defense 74
Administration of a multi-strain probiotic product to women in the perinatal period differentially affects the breast milk cytokine profile and may have beneficial effects on neonatal gastrointestinal functional symptoms. A randomized clinical trial 72
Assessment of fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon 71
Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces 59
null 57
A probiotic preparation hydrolyzes gliadin and protects intestinal cells from the toxicity of pro-inflammatory peptides 38
C’è vita nell’intestino: la risposta microbica allo stress 35
Cell wall components of a Lactobacillus brevis strain inhibit herpes simplex virus type 2 replication 34
Bacterial-based strategies to hydrolyze gluten peptides and protect intestinal mucosa 34
Bioactive factors of maternal breast milk and fecal microbiota of infants 32
Inibition of rhinovirus infection by Lactobacillus brevis 27
null 20
Urinary metabolic profiling and symptomatic uncomplicated diverticular disease of the colon 13
Faecalibacterium prausnitzii is not decreased in symptomatic uncomplicated diverticular disease of the colon 11
Analysis of microbiota and metaboloma in symptomatic uncomplicated diverticular disease of the colon 7
Totale 899
Categoria #
all - tutte 2.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 12 31 24
2019/2020225 34 8 0 5 22 32 28 23 25 28 12 8
2020/202172 6 9 6 1 2 4 0 6 11 17 7 3
2021/2022159 0 8 16 15 19 3 3 15 7 11 38 24
2022/2023167 28 34 8 11 10 14 11 12 27 1 11 0
2023/202497 3 14 5 4 22 20 1 14 0 14 0 0
Totale 899